Pregabalin is used to treat nerve pain from diabetes or shingles, and it also helps reduce seizures and anxiety. It works by calming overactive nerves in the body that cause pain and other symptoms.[2] Lyrica is currently approved and in use across 89 indications[4].[1]
Lyrica is one of 1382 small molecule programs targeting Refractive Error. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
2828 competitors in Breast Cancer
Lyrica
Tykerb
Nolvadex
Prolia
DATROWAY
Lupron
MS Contin
Tricor
Cortef
Acupan
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Dec 30, 2004
LYRICA
NDA NDA021446
Jan 4, 2010
LYRICA
NDA NDA022488
Oct 11, 2017
LYRICA CR
NDA NDA209501
Sources
Details
Patent Cliff
Nov 2, 2026
Earliest patent expiration — generic entry possible after this date